Ara
Toplam kayıt 3, listelenen: 1-3
Concomitant bladder tumor is a risk factor for bladder recurrence but not upper tract
(MDPI, 2022)
Objective: To evaluate the clinical outcomes of UTUC patients with or without concurrent bladder tumor. Design, Setting, and Participants: The Clinical Research Office of the Endourology Society-Urothelial Carcinomas of ...
Impact of adjuvant gemcitabine containing chemotherapy following radical nephroureterectomy for patients with upper tract urothelial carcinoma: Results from a propensity-score matched cohort study
(IOS Press BV, 2023)
BACKGROUND: The evidence regarding perioperative adjuvant chemotherapy and personalized surveillance strategies for upper tract urothelial carcinoma is limited.
OBJECTIVE: To evaluate whether adjuvant gemcitabine ...
The prognostic role of body mass index on oncological outcomes of upper tract urothelial carcinoma
(Multidisciplinary Digital Publishing Institute (MDPI), 2023)
Simple Summary In patients with upper tract urothelial carcinoma, the impact of body mass index on oncological outcomes is still a matter of debate. We use the Clinical Research Office of the Endourology Society Urothelial ...